(Q43571484)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

optical coherence tomography

6 November 2019

main subject

1 reference

inferred from title

cystoid macular edema

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

R J Antcliff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D J Spalton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M R Stanford

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

E M Graham

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T J ffytche

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

765-772

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

Causes and frequency of blindness in patients with intraocular inflammatory disease

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Clinical and experimental observation on the use of ACTH and cortisone in ocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Hydrocortisone in ophthalmology

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Use of steroids and immunosuppressive drugs in the management of posterior uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Orbital floor steroid injections in the treatment of uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Cyclosporin in the treatment of severe chronic idiopathic uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Long-term results of pars plana vitrectomy in the management of complicated uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Immunosuppressive drugs in immune and inflammatory ocular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Macular ischaemia in posterior uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Inhibition of Intraocular Proliferations with Intravitreal Corticosteriods

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Exudative macular degeneration and intravitreal triamcinolone. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Optical coherence tomography of the human retina

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Quantitative assessment of macular edema with optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Patterns of diabetic macular edema with optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Imaging of macular diseases with optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Pathology of cystoid macular edema.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Topography of diabetic macular edema with optical coherence tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Evaluation of the Retinal Toxicity and Pharmacokinetics of Dexamethasone After Intravitreal Injection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

The lack of toxicity of intravitreally administered triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

An intravitreal device providing sustained release of cyclosporine and dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Effect of structural alterations on the photosensitizing potency of furocoumarins (psoralens) and related compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

The neuroprotective pharmacology of methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

The pathogenesis of edema in diabetic maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900658-8

7 January 2021

10.1016/S0161-6420(00)00658-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297495%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference